Fig. 4: Associations of NAFLD and metabolic factors with CKD by two-sample MR analysis.

MR Mendelian randomization, CKD chronic kidney disease, NAFLD non-alcoholic fatty liver disease, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, TG triglycerides, HDL-C high-density lipoprotein cholesterol, OR odds ratio, CI confidence interval.